US 8,771,691 B2Granted

Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma

AssigneeInserm (Institut National De La Sante Et De La Recherche Medicale)

InventorsPatricia Forgez, Marco Alifano

Life of this patent

Estimating the term…

Abstract

The present invention relates to methods for the treatment and the prognostic assessment of malignant pleural mesothelioma.

Claims5

Dependent claims

A method for the treatment of malignant pleural mesothelioma, wherein an inhibitor of the neurotensin activation of neurotensin receptor 1 (NTSR1) is administered to a subject in need thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/139,907Filed 14 Dec 2009
Priority: EP 0830597118 Dec 2008
Published: US 2011/0300161 A18 Dec 2011
Granted: 8 Jul 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

C07K 16/26
Against material from animals or humans: against hormones ; against hormone releasing or inhibiting factors
A61K 31/4709
Quinolines; Isoquinolines: non-condensed quinolines and containing further heterocyclic rings
A61K 38/4813
Acting on peptide bonds: exopeptidases
A61K 38/482
Acting on peptide bonds: serine endopeptidases

Family

US 2011/0300161 A1Pre-grant publication · published 8 Dec 2011
US 8,771,691 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results